The Role of Immunohistochemistry in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: An Old Tool With an Enduring Prognostic Value
Micro-Abstract Pathologic complete response (pCR) to neoadjuvant chemotherapy is a potential surrogate for survival. We defined molecular subtypes determined by hormonal receptors (HR) and human epidermal growth factor receptor 2 (HER2) status. pCR was significantly higher in patients with HR− /HER2...
Gespeichert in:
Veröffentlicht in: | Clinical breast cancer 2013-04, Vol.13 (2), p.146-152 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!